Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |